Skip to main content
. 2021 Jan 8;11:137. doi: 10.1038/s41598-020-80603-8

Figure 9.

Figure 9

Comparison of change in HbA1c (%) from baseline between patients who were on metformin-SGIT2I and metformin-sulphonylureas combination therapies. SD standard deviation; CI confidence interval; MD mean difference; Met metformin; SGLT2I sodium glucose co-transporter 2 inhibitor; SU sulfonylurea.